Search Results

You are looking at 71 - 80 of 152 items for :

Clear All
Full access

Rebecca H. Johnson and Leah Kroon

specialists in reproductive endocrinology and urology is a key element in developing a robust system for fertility preservation in any oncology practice. Fertility clinics partnering with oncology practices must understand the highly time-sensitive nature of

Full access

Richard S. Matulewicz, Brendan T. Frainey, Daniel T. Oberlin and Joshua J. Meeks

. Urology 2014 ; 84 : 881 – 885 . 21. Dutta SC Smith JA Jr Shappell SB . Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy . J Urol 2001 ; 166 : 490 – 493 . 22. Mungan NA

Full access

Marina Deuker, Giuseppe Rosiello, Lara Franziska Stolzenbach, Thomas Martin, Claudia Collà Ruvolo, Luigi Nocera, Zhe Tian, Frederik C. Roos, Andreas Becker, Luis A. Kluth, Derya Tilki, Shahrokh F. Shariat, Fred Saad, Felix K.H. Chun and Pierre I. Karakiewicz

. 11 Conversely, the European Association of Urology guidelines 8 do not mention bone imaging at all but rely on CT scan as the preferred diagnostic technique for lung and abdominal staging of metastases. Second, we identified a low rate of brain

Full access

Lara Franziska Stolzenbach, Giuseppe Rosiello, Angela Pecoraro, Carlotta Palumbo, Stefano Luzzago, Marina Deuker, Zhe Tian, Anne-Sophie Knipper, Raisa Pompe, Kevin C. Zorn, Shahrokh F. Shariat, Felix K.H. Chun, Markus Graefen, Fred Saad and Pierre I. Karakiewicz

disparities in oncologic outcomes after radical prostatectomy: long-term follow-up . Urology 2014 ; 84 : 1434 – 1441 . 25432835 10.1016/j.urology.2014.08.039

Full access

Carlotta Palumbo, Francesco A. Mistretta, Sophie Knipper, Angela Pecoraro, Zhe Tian, Shahrokh F. Shariat, Fred Saad, Claudio Simeone, Alberto Briganti, Alessandro Antonelli and Pierre I. Karakiewicz

been adopted by either European Association of Urology 15 or NCCN 16 guidelines, especially for patients with pT1aN0 and pT1bN0 disease. Despite the strengths of this study, important limitations need to be acknowledged. First, our data represents a

Full access

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Sam Bhayani, William P. Bro, Sam S. Chang, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Mayer Fishman, Thomas H. Gallagher, John L. Gore, Steven L. Hancock, Michael R. Harrison, Won Kim, Christos Kyriakopoulos, Chad LaGrange, Elaine T. Lam, Clayton Lau, M. Dror Michaelson, Thomas Olencki, Phillip M. Pierorazio, Elizabeth R. Plimack, Bruce G. Redman, Brian Shuch, Brad Somer, Guru Sonpavde, Jeffrey Sosman, Mary Dwyer and Rashmi Kumar

indicator of renal cell carcinoma aggressiveness . Cancer 2005 ; 104 : 511 – 520 . 17. Jayson M Sanders H . Increased incidence of serendipitously discovered renal cell carcinoma . Urology 1998 ; 51 : 203 – 205 . 18. Luciani LG

Full access

Crystal S. Denlinger, Tara Sanft, K. Scott Baker, Shrujal Baxi, Gregory Broderick, Wendy Demark-Wahnefried, Debra L. Friedman, Mindy Goldman, Melissa Hudson, Nazanin Khakpour, Allison King, Divya Koura, Elizabeth Kvale, Robin M. Lally, Terry S. Langbaum, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Javid J. Moslehi, Tracey O'Connor, Linda Overholser, Electra D. Paskett, Jeffrey Peppercorn, M. Alma Rodriguez, Kathryn J. Ruddy, Paula Silverman, Sophia Smith, Karen L. Syrjala, Amye Tevaarwerk, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Deborah A. Freedman-Cass and Nicole R. McMillian

, treatment of male sexual dysfunction may require a multidimensional treatment plan that addresses the underlying issues. Referrals to specialists (ie, psychotherapy, sexual/couples counseling, urology, sexual health specialist) should be made if appropriate

Full access

Allan Lipton, Robert Uzzo, Robert J. Amato, Georgiana K. Ellis, Behrooz Hakimian, G. David Roodman and Matthew R. Smith

Akashi T Furuya Y Ohta S Fuse H . Tissue factor expression and prognosis in patients with metastatic prostate cancer . Urology 2003 ; 62 : 1078 – 1082 . 56 Smid M Wang Y Klijn JG . Genes associated with breast cancer metastatic to bone

Full access

James L. Mohler, Andrew J. Armstrong, Robert R. Bahnson, Anthony Victor D'Amico, Brian J. Davis, James A. Eastham, Charles A. Enke, Thomas A. Farrington, Celestia S. Higano, Eric M. Horwitz, Michael Hurwitz, Christopher J. Kane, Mark H. Kawachi, Michael Kuettel, Richard J. Lee, Joshua J. Meeks, David F. Penson, Elizabeth R. Plimack, Julio M. Pow-Sang, David Raben, Sylvia Richey, Mack Roach III, Stan Rosenfeld, Edward Schaeffer, Ted A. Skolarus, Eric J. Small, Guru Sonpavde, Sandy Srinivas, Seth A. Strope, Jonathan Tward, Dorothy A. Shead and Deborah A. Freedman-Cass

MW Potters L Blasko JC . Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer . Urology 2001 ; 58 : 393 – 399 . 12. Potters L Morgenstern C Calugaru E . 12-year outcomes

Full access

Peter E. Clark, Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Jason A. Efstathiou, Thomas W. Flaig, Terence Friedlander, Richard E. Greenberg, Khurshid A. Guru, Noah Hahn, Harry W. Herr, Christopher Hoimes, Brant A. Inman, A. Karim Kader, Adam S. Kibel, Timothy M. Kuzel, Subodh M. Lele, Joshua J. Meeks, Jeff Michalski, Jeffrey S. Montgomery, Lance C. Pagliaro, Sumanta K. Pal, Anthony Patterson, Daniel Petrylak, Elizabeth R. Plimack, Kamal S. Pohar, Michael P. Porter, Wade J. Sexton, Arlene O. Siefker-Radtke, Guru Sonpavde, Jonathan Tward, Geoffrey Wile, Mary A. Dwyer and Courtney Smith

. Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials . Urology 2006 ; 67 : 1216 – 1223 . 4 Shelley MD Kynaston H Court J . A systematic review of